GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (OSTO:BIOG B) » Definitions » E10

BioGaia AB (OSTO:BIOG B) E10 : kr3.00 (As of Mar. 2025)


View and export this data going back to 1998. Start your Free Trial

What is BioGaia AB E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BioGaia AB's adjusted earnings per share data for the three months ended in Mar. 2025 was kr0.790. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr3.00 for the trailing ten years ended in Mar. 2025.

During the past 12 months, BioGaia AB's average E10 Growth Rate was 6.00% per year. During the past 3 years, the average E10 Growth Rate was 9.60% per year. During the past 5 years, the average E10 Growth Rate was 9.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of BioGaia AB was 10.90% per year. The lowest was 8.20% per year. And the median was 9.30% per year.

As of today (2025-07-13), BioGaia AB's current stock price is kr106.50. BioGaia AB's E10 for the quarter that ended in Mar. 2025 was kr3.00. BioGaia AB's Shiller PE Ratio of today is 35.50.

During the past 13 years, the highest Shiller PE Ratio of BioGaia AB was 61.09. The lowest was 32.78. And the median was 43.08.


BioGaia AB E10 Historical Data

The historical data trend for BioGaia AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB E10 Chart

BioGaia AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.09 2.27 2.46 2.85 2.99

BioGaia AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.83 2.92 2.93 2.99 3.00

Competitive Comparison of BioGaia AB's E10

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Shiller PE Ratio falls into.


;
;

BioGaia AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioGaia AB's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.79/132.8245*132.8245
=0.790

Current CPI (Mar. 2025) = 132.8245.

BioGaia AB Quarterly Data

per share eps CPI Adj_EPS
201506 0.412 99.995 0.547
201509 0.238 100.228 0.315
201512 0.250 100.276 0.331
201603 1.234 100.751 1.627
201606 0.444 101.019 0.584
201609 0.404 101.138 0.531
201612 0.542 102.022 0.706
201703 0.494 102.022 0.643
201706 0.544 102.752 0.703
201709 0.486 103.279 0.625
201712 0.558 103.793 0.714
201803 0.498 103.962 0.636
201806 0.644 104.875 0.816
201809 0.594 105.679 0.747
201812 0.740 105.912 0.928
201903 0.412 105.886 0.517
201906 0.704 106.742 0.876
201909 0.438 107.214 0.543
201912 0.588 107.766 0.725
202003 0.482 106.563 0.601
202006 0.904 107.498 1.117
202009 0.234 107.635 0.289
202012 0.404 108.296 0.496
202103 0.500 108.360 0.613
202106 0.540 108.928 0.658
202109 0.520 110.338 0.626
202112 0.380 112.486 0.449
202203 0.760 114.825 0.879
202206 0.780 118.384 0.875
202209 0.790 122.296 0.858
202212 1.380 126.365 1.451
202303 1.150 127.042 1.202
202306 0.800 129.407 0.821
202309 1.010 130.224 1.030
202312 0.670 131.912 0.675
202403 1.210 132.205 1.216
202406 1.100 132.716 1.101
202409 0.360 132.304 0.361
202412 0.810 132.987 0.809
202503 0.790 132.825 0.790

Add all the adjusted EPS together and divide 10 will get our e10.


BioGaia AB  (OSTO:BIOG B) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

BioGaia AB's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=106.50/3.00
=35.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of BioGaia AB was 61.09. The lowest was 32.78. And the median was 43.08.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BioGaia AB E10 Related Terms

Thank you for viewing the detailed overview of BioGaia AB's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


BioGaia AB Business Description

Address
Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

BioGaia AB Headlines

No Headlines